N Thielen1, G J Ossenkoppele, G-J Schuurhuis, J J W M Janssen. Show Affiliations » 1. Department of Haematology, VU University Medical Center, Amsterdam, the Netherlands. n.thielen@vumc.nl
Abstract
Entities: Disease
Mesh： See more » BenzamidesDisease ProgressionFusion Proteins, bcr-abl/geneticsFusion Proteins, bcr-abl/metabolismGenes, ablHumansImatinib MesylateLeukemia, Myelogenous, Chronic, BCR-ABL Positive/drug therapyLeukemia, Myelogenous, Chronic, BCR-ABL Positive/geneticsLeukemia, Myelogenous, Chronic, BCR-ABL Positive/metabolismPiperazines/therapeutic useProtein Kinase Inhibitors/therapeutic useProtein-Tyrosine Kinases/geneticsProtein-Tyrosine Kinases/metabolismPyrimidines/therapeutic useSignal Transduction/genetics
Substances： See more » BenzamidesPiperazinesProtein Kinase InhibitorsPyrimidinesImatinib MesylateProtein-Tyrosine KinasesFusion Proteins, bcr-abl
Year: 2011 PMID： 22058262
Source DB: PubMed Journal: Neth J Med ISSN： 0300-2977 Impact factor: 1.422